Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
Sep 3, 2026, 00:14

Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases

Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared a post on LinkedIn about a recent article by Nathan W. Watson et al, published in Stroke, adding:

“Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-analysis

Antiphospholipid antibodies (aPL) are associated with an increased risk of thrombosis.

However, individual studies have reported conflicting findings regarding the prevalence of aPL in patients with ischemic stroke and their association with initial or recurrent events.

Seropositivity for any aPL was observed in nearly 1 in 5 patients with ischemic stroke and was associated with a higher likelihood of ischemic stroke at clinical presentation.”

Title: Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-Analysis

Authors: Nathan W. Watson, Syed Bukhari, Sina Rashedi, Mariana Pfeferman, Francisco Ujueta, Bassil Bacare, Brittany N. Weber, Mehrdad Zarghami, Yogendra Kanthi, Eric A. Secemsky, Jean M. Connors, Geoffrey D. Barnes, Sacha Uljon, Samuel Z. Goldhaber, Jeffrey I. Weitz, Karen H. Costenbader, Harlan M. Krumholz, Gregory Piazza, Mary Cushman, Christopher D. Anderson, Mitchell S. V. Elkind, Behnood Bikdeli

Leonardo Roever

Other posts featuring Leonardo Roever on Hemostasis Today.